glp-1 thyroid cancer risk GLP-1RA and cancer: New study suggests detection bias, not causation Glucagon-like peptide 1 receptor agonists
Description
This is where a structured, supportive approach makes a difference
"That person might lose really a lot of weight and suffer nutritionally." It's also unclear how long people with substance use disorder would need to take a GLP-1 drug
doi: 10.3389/fendo.2021.721198 [DOI] [PMC free article] [PubMed] [Google Scholar] 23
The supply is beginning to stabilize, but certain doses may still be limited or sell out quicklyespecially in high-demand areas
